Where do we stand in enzyme replacement therapy in Pompe's disease?
Neuromuscul Disord
.
2010 Dec;20(12):773-4.
doi: 10.1016/j.nmd.2010.09.011.
Author
A T van der Ploeg
PMID:
21094929
DOI:
10.1016/j.nmd.2010.09.011
No abstract available
Publication types
Comment
Editorial
MeSH terms
Enzyme Replacement Therapy*
Glucan 1,4-alpha-Glucosidase / therapeutic use*
Glycogen Storage Disease Type II / therapy*
Humans
Substances
Glucan 1,4-alpha-Glucosidase